Canton Hathaway, LLC Novavax Inc Transaction History
Canton Hathaway, LLC
- $495 Million
- Q1 2025
Shares
3 transactions
Others Institutions Holding NVAX
# of Institutions
299Shares Held
90.4MCall Options Held
5.76MPut Options Held
6.65M-
Vanguard Group Inc Valley Forge, PA15.7MShares$116 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$87.4 Million0.0% of portfolio
-
Shah Capital Management11.1MShares$82.2 Million33.15% of portfolio
-
State Street Corp Boston, MA7.04MShares$51.9 Million0.0% of portfolio
-
Coatue Management LLC New York, NY3.84MShares$28.3 Million0.13% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $577M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...